Boothbay Fund Management »

Karyopharm Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 145k 7.36

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Opaleye Management
Affinity Asset Advisors
Susquehanna International
Vanguard Group
Ikarian Capital
Soleus Capital Management
Adage Capital Partners GP
Davidson Kempner Capital Management
Braidwell
BlackRock
Geode Capital Management
Boothbay Fund Management
Catalio Capital Management
Avidity Partners Management

View all funds holding Karyopharm Therapeutics